Value of nevirapine for preventing MTCT of HIV infections in Africa

August 2004
PharmacoEconomics & Outcomes News;8/14/2004, Issue 459, p11
Discusses research being done on the cost effectiveness of nevirapine treatment for the prevention of mother-to-child transmission of HTV infections across African countries. Reference to a study by M. D. Sweat, et al published in the August 2004 issue of "AIDS"; Number of HIV infections averted annually in Botswana and Tanzania; Annual national cost associated with intervention programmes; Average cost per HIV infection averted in Botswana and Côte d'Ivore.


Related Articles

  • NIH to study immune system supplement in HIV-infected women.  // Public Health Reports;May/Jun94, Vol. 109 Issue 3, p458 

    Discusses a planned three-year study of the effects of an immune system supplement on HIV transmission from infected pregnant women to their offspring. Involvement of three agencies of the National Institutes of Health; Examination of the effectiveness of HIVIG, an immune globulin preparation.

  • Descriptive survey of antenatal HIV testing in London: Policy, uptake, and detection. MacDonagh, Sandra E.; Masters, Janet // BMJ: British Medical Journal (International Edition);8/31/96, Vol. 313 Issue 7056, p532 

    Presents a study of antenatal HIV testing in London, England. Policy governing the practice of HIV testing among pregnant women; Number of women who elected to undergo HIV testing; Concern over the increasing number of mother to child transmission of HIV.

  • State tackle laws about testing pregnant women for AIDS virus.  // Nation's Health;Mar96, Vol. 26 Issue 3, p8 

    Focuses on the interest in testing pregnant women for the AIDS virus. Legal issues; Offering of counseling on the value of the test; Controversies surrounding the testing of pregnancy women for the virus.

  • Mothers' voices. Nevins., Barbara // Redbook;May93, Vol. 181 Issue 1, p96 

    Presents the stories of nine mothers, some whose children are infected, others who have lost a child to AIDS and some who are infected themselves. How many have been shunned, abandoned or harassed; Their hope that their stories might help save lives; Details.

  • Sheep protein.  // Science Teacher;Nov97, Vol. 64 Issue 8, p12 

    States that with early treatment of a protein from pregnant sheep, the development of the Acquired Immune Deficiency Syndrome (AIDS) can be blocked in babies born to HIV-infected mothers. Factors which influenced the discovery; Reference to those involved in the discovery; Advantages of the...

  • Protection from mother.  // Discover;Feb94, Vol. 15 Issue 2, p18 

    Explains how fetuses carried by AIDS infected women are protected by the trophoblast cells. Absence of CD4 in trophoblast; Reason for cases on infection; Immune response triggered by CD4 evolution.

  • Erratum: Vol. 52, No. 8.  // MMWR: Morbidity & Mortality Weekly Report;3/7/2003, Vol. 52 Issue 9, p191 

    Presents a correction to the article 'Pregnancy in Perinatally HIV-Infected Adolescents and Young Adults--Puerto Rico, 2002.'

  • AZT blocks HIV in newborns.  // Joe Weider's Muscle & Fitness;Sep94, Vol. 55 Issue 9, p44 

    Reports on a study on the benefit of the anti-AIDS drug AZT on an infected pregnant woman's fetus. Ability to prevent transmission of HIV from an infected pregnant woman to her fetus; Percentage of fetal infection in the AZT group compared to the placebo group.

  • Results from Ugandan programme preventing maternal transmission of HIV. Giuliano, Marina; Magoni, Michele; Bassani, Luciana; Okong, Pius; Namaganda, Praxedes Kituka; Onyango, Saul // BMJ: British Medical Journal (International Edition);10/1/2005, Vol. 331 Issue 7519, p778 

    Presents a letter to the editor in response to an article about a Ugandan program preventing maternal transmission of HIV.


Other Topics